Edinburgh, United Kingdom

Hannah Ruth McLachlan

This inventor holds 3 USPTO granted patents. Top assignee: Aldeyra Therapeutics, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hannah Ruth McLachlan. Retrieved from https://idiyas.com/inventor/hannah-ruth-mclachlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hannah Ruth McLachlan

Introduction

Hannah Ruth McLachlan is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of small molecule therapeutics, particularly in the area of toxic aldehyde scavenging. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Hannah's latest patents include innovative formulations of polymorphic compounds. One of her notable inventions relates to free-base and salt forms, as well as compositions of small molecule therapeutics that act as scavengers for toxic aldehydes. This invention is crucial for treating diseases, disorders, or conditions where aldehyde toxicity plays a role in their pathogenesis. Another patent also focuses on polymorphic compounds, providing methods and compositions useful for addressing various conditions linked to aldehyde toxicity.

Career Highlights

Hannah is currently associated with Aldeyra Therapeutics, Inc., where she continues to develop her groundbreaking work. Her research is instrumental in creating therapeutic solutions that can significantly improve patient outcomes.

Collaborations

Hannah collaborates with talented individuals in her field, including Stephen Gitu Machatha and Jonathan James Loughrey. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Hannah Ruth McLachlan's contributions to the field of therapeutics demonstrate her commitment to addressing critical health challenges. Her innovative patents and collaborations position her as a key figure in the ongoing fight against diseases linked to aldehyde toxicity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…